HC Wainwright & Co. Maintains Buy on Alto Neuroscience, Raises Price Target to $60

Benzinga · 1d ago
HC Wainwright & Co. analyst Patrick R. Trucchio maintains Alto Neuroscience (NYSE:ANRO) with a Buy and raises the price target from $55 to $60.